| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/08/2010 | EP1382336B1 Use of the abc expression promotor pioglitazone for the treatment of arteriosclerosis obliterans |
| 09/08/2010 | EP1347787B2 Use of dexpanthenol in contact lens care compositions |
| 09/08/2010 | EP1320531B1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/08/2010 | EP1263759B1 Azaindoles |
| 09/08/2010 | EP1261325B1 Tumor inhibiting compositions comprising nitroacridines |
| 09/08/2010 | EP1257538B1 9-alkylamino-1-nitroacridine derivatives |
| 09/08/2010 | EP0882717B1 Nitrogenous heterocyclic compounds |
| 09/08/2010 | EP0770132B1 New streptogramines |
| 09/08/2010 | CN201572341U Compound amlodipine besylate atorvastatin calcium tablet |
| 09/08/2010 | CN1997362B Chewable, suckable and swallowable tablet containing a caicium-containing compound as an active substance |
| 09/08/2010 | CN1993354B Preparation of hydrochloride salts of tetrazole derivative |
| 09/08/2010 | CN1974560B Compound 3-isopropyl-6-(2-methylbutyl) piperazine-2,5-dione and its preparation and application |
| 09/08/2010 | CN1973853B Hemostatic and analgetic medicine composition and its preparation process |
| 09/08/2010 | CN1968929B Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 09/08/2010 | CN1965885B Application of total flavones of chickpea in preparation of medicament for treating diabetes |
| 09/08/2010 | CN1960723B Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight |
| 09/08/2010 | CN1960722B Use of furan alkyl for preparing an antidiabetic drug |
| 09/08/2010 | CN1958024B Chinese traditional medicine for treating coronary heart disease, angina pectoris, and preparation |
| 09/08/2010 | CN1958007B Vagina tablet for treating cervicitis, cervical erosion, and preparation method |
| 09/08/2010 | CN1954839B Medical composition prepared by caulis Marsdeniae Tenacissimae, ginseng and astragalus root |
| 09/08/2010 | CN1950376B Curcumol derivatives, compositions comprising the same and use in manufacture of medicament |
| 09/08/2010 | CN1943591B Castrating liquid for animal |
| 09/08/2010 | CN1931220B Medicine paste for treating burns and scalds and its preparation process |
| 09/08/2010 | CN1923205B Application of (-)doxazosin in preparing medicine for treating lower urinary tract symptom and bladder excessive activities diseases |
| 09/08/2010 | CN1919874B Antibody molecule ATF-Fc fusion albumen of antiurokinase type fibrinolysin activator receptor and use thereof |
| 09/08/2010 | CN1915221B Liposome of alkaloid in vinca, and preparation method |
| 09/08/2010 | CN1893926B Stable liposome compositions comprising lipophilic amine containing pharmaceutical agents |
| 09/08/2010 | CN1882315B Solid pharmaceutical preparation form |
| 09/08/2010 | CN1879814B Antivirus medicine for birds and method for preparing same |
| 09/08/2010 | CN1853640B Doxycycline hyclate liposome and production thereof |
| 09/08/2010 | CN1850812B Imidazole derivative, and its preparing method and use for pharmaceutical for tubercle bacillus |
| 09/08/2010 | CN1850078B Anti-platelet aggregation medicinal injection and its preparing method |
| 09/08/2010 | CN1842341B Active fraction having anti-cancer and anti-metastic activity isolated from leaves and stems of ginseng |
| 09/08/2010 | CN1833674B Wart gel and preparation method |
| 09/08/2010 | CN1830451B Preparation method of erigeron breviscapus glucese injection |
| 09/08/2010 | CN1829518B Use of brimonidine in preparing medicine for treating or preventing rosacea and its symptom |
| 09/08/2010 | CN1826105B Use of amphetamine composition in producing medicine for treating cognitive impairment |
| 09/08/2010 | CN1816327B Use of HIF alpha stabilizers for enhancing erythropoiesis |
| 09/08/2010 | CN1798746B Reverse-turn mimetics and method relating thereto |
| 09/08/2010 | CN1778300B Luotongding oral cavity disintegration tablet and preparation thereof |
| 09/08/2010 | CN1777418B Composition for slimming |
| 09/08/2010 | CN1772073B Medicine composition for treating throat and oral cavity diseases and its preparation process |
| 09/08/2010 | CN1738620B Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
| 09/08/2010 | CN1736381B Use of morpholine methyltetralone in preparation of smooth muscles spasmolytic |
| 09/08/2010 | CN1732154B Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 09/08/2010 | CN1689575B Application of ocotillol in the preparing process of medicine for treating or preventing cardiovascular and cerebrovascular disease |
| 09/08/2010 | CN1688343B Modified saccharides, conjugates thereof, and their manufacture |
| 09/08/2010 | CN1662224B Agent for producing a sensation of satiety and for weight loss |
| 09/08/2010 | CN1659144B Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 09/08/2010 | CN1566342B Antigenic epitope of S-protein of SARS coronavirus, antibody of S-protein of SARS coronavirus , nucleic acid encoding S-protein of SARS coronavirus and compositions containing same |
| 09/08/2010 | CN101827936A CDH3 peptide and medicinal agent comprising the same |
| 09/08/2010 | CN101827856A 2 ' -flu0r0-2 ' -deoxytetrahydrouridines as cytidine deaminase inhibitors |
| 09/08/2010 | CN101827853A Heterocycle-substituted piperazino-dihydrothienopyrimidines |
| 09/08/2010 | CN101827852A Substituted piperidino-dihydrothienopyrimidines |
| 09/08/2010 | CN101827851A 5-cyano-thienopyridines for the treatment of tumors |
| 09/08/2010 | CN101827848A 2- [ (2-{phenylamino}-1H-pyrrolo [2, 3-d] pyrimidin-4-yl) amino] benzamide derivatives as iIGF-1R inhibitors for the treatment of cancer |
| 09/08/2010 | CN101827847A Purine derivatives as adenosine al receptor ligands |
| 09/08/2010 | CN101827846A Valomaciclovir polymorphs |
| 09/08/2010 | CN101827845A Cgrp antagonists |
| 09/08/2010 | CN101827844A Imidazo [1,2-a] pyridine derivatives useful as ALK inhibitors |
| 09/08/2010 | CN101827843A Method for producing pyrazole fused ring derivative |
| 09/08/2010 | CN101827842A Oxadiazole derivatives as dgat inhibitors |
| 09/08/2010 | CN101827841A (R)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
| 09/08/2010 | CN101827840A Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators |
| 09/08/2010 | CN101827839A 1,3,5-trisubstituted triazole derivative |
| 09/08/2010 | CN101827836A Trisubstituted 1,2,4-triazoles |
| 09/08/2010 | CN101827832A Acetamide derivatives as glucokinase activators, their process and medicinal applications |
| 09/08/2010 | CN101827828A 1, 2, 4 -triazole derivatives as serotonergic modulators |
| 09/08/2010 | CN101827827A 6-aryl/heteroalkyloxy benzothiazole and benzimidazole derivatives, method for preparing same, application thereof as drugs, pharmaceutical compositions and novel use in particular as C-MET inhibitors |
| 09/08/2010 | CN101827826A 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof |
| 09/08/2010 | CN101827825A Crystalline chemotherapeutic |
| 09/08/2010 | CN101827824A Crystalline chemotherapeutic |
| 09/08/2010 | CN101827823A Crystalline chemotherapeutic |
| 09/08/2010 | CN101827822A Crystalline indazole-derived chemotherepeutic |
| 09/08/2010 | CN101827821A Crystalline chemotherapeutic |
| 09/08/2010 | CN101827820A Aminopyrazole amide derivative |
| 09/08/2010 | CN101827819A Quaternary opioid carboxamides |
| 09/08/2010 | CN101827816A Therapeutic agent for TRPV1-mediated disease |
| 09/08/2010 | CN101827807A Method for producing mechanically activated amorphous and amorphocrystalline compounds of gluconic acid calcium salt |
| 09/08/2010 | CN101827806A Anti-bacterial agents |
| 09/08/2010 | CN101827613A Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
| 09/08/2010 | CN101827612A Buffer solutionsha ving selective bactericidal activity against gramnegative bacteria and methods of using same |
| 09/08/2010 | CN101827601A Anti-cancer composition comprising microRNA molecules |
| 09/08/2010 | CN101827600A Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria |
| 09/08/2010 | CN101827599A Process for synthesizing phosphonic and phosphinic acid compounds |
| 09/08/2010 | CN101827598A Pharmaceutical combination of opioid and prostaglandin compound |
| 09/08/2010 | CN101827597A Treatment of sleep disorders |
| 09/08/2010 | CN101827596A Combination comprising purine derivatives and other compounds and the use thereof for the treatment of inflammatory and obstructive airway diseases |
| 09/08/2010 | CN101827595A Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor |
| 09/08/2010 | CN101827594A Combination therapy for reducing side effects using cannabinoid receptor ligands |
| 09/08/2010 | CN101827593A Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis |
| 09/08/2010 | CN101827592A Methods for treating post-operative effects such as spasticity and shivering with clonidine |
| 09/08/2010 | CN101827591A Combination of checkponit kinase ( CHK) and telangiectasia mutated (ATM) inhibitors for the treatment of cancer |
| 09/08/2010 | CN101827590A Bilayer composition for the sustained release of acetaminophen and tramadol |
| 09/08/2010 | CN101827589A Hepatitis c antiviral compositions and methods |
| 09/08/2010 | CN101827588A Novel nutraceutical compositions containing thymol and/or p-cymene or plant extracts for cognition |
| 09/08/2010 | CN101827587A Formulations of organo-platinic compounds in the presence of associative polymers, products thus obtained and uses thereof |
| 09/08/2010 | CN101827585A Solid dispersion product containing N-aryl urea-based compound |
| 09/08/2010 | CN101827584A Solid dispersion product of N-aryl urea-based drugs |
| 09/08/2010 | CN101827525A Kinase inhibitor compounds |